Literature DB >> 7049502

Responses to captopril and hydrochlorothiazide in black patients with hypertension.

M Moser, J Lunn.   

Abstract

The effects of captopril (C) in doses of up to 450 mg/day, placebo (P), and hydrochlorothiazide (H) in doses of 50 to 100 mg/day were compared in double-blind studies in 38 black patients. Mean blood pressure response to C was only slightly greater than to P (systolic response difference only). Mean blood pressure responses to H were greater than to C. Results were compared to available data on 185 white and black patients treated similarly. In white patients, response to C was greater than to P, but response to H was approximately equal to that to C. In black patients, results were of the same order as those reported here; the systolic response to C was greater than that to P and response to H was greater than that to C. These data suggest that black and white patients differ in response to certain antihypertensive drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049502     DOI: 10.1038/clpt.1982.165

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  24 in total

1.  Risk for osteoporosis in black women.

Authors:  J F Aloia; A Vaswani; J K Yeh; E Flaster
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

Review 2.  Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.

Authors:  J A Balfour; K L Goa
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 3.  Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium, and calcium regulation.

Authors:  A Aviv; M Aladjem
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

4.  Racial differences in hypertension: implications for high blood pressure management.

Authors:  Daniel T Lackland
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

Review 5.  Antihypertensive treatment according to age, plasma renin and race.

Authors:  F R Bühler
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 6.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

7.  Propranolol versus labetalol: interesting differences in efficacy.

Authors:  W Flamenbaum
Journal:  J Natl Med Assoc       Date:  1985-05       Impact factor: 1.798

8.  The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension.

Authors:  Gary L Schwartz; Kent Bailey; Arlene B Chapman; Eric Boerwinkle; Stephen T Turner
Journal:  Am J Hypertens       Date:  2013-04-16       Impact factor: 2.689

9.  The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.

Authors:  C Lucas; P Jenkins; J Mendels; D Due; W P Forbes; M A Sirgo
Journal:  J Natl Med Assoc       Date:  1991-10       Impact factor: 1.798

10.  Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension.

Authors:  Kamel A Gharaibeh; Stephen T Turner; Abdurrahman M Hamadah; Arlene B Chapman; Rhonda M Cooper-Dehoff; Julie A Johnson; John G Gums; Kent R Bailey; Gary L Schwartz
Journal:  Am J Hypertens       Date:  2016-06-30       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.